Search research articles
Contact Us
Filters
Showing results (381-390 of 498) with videos related to
Page
of 50
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer
Liat Hammer, Ralph Jiang, Jason Hearn, et al.
JCO Precision Oncology
|
June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
Angela Y Jia, Yilun Sun, Maitry Patel, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)
Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
JCO Precision Oncology
|
October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
Journal of the National Cancer Institute
|
October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Cancer
|
April 15, 2023
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes
Adam B Weiner, Yang Liu, Alex Hakansson, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
Practical Radiation Oncology
|
November 26, 2019
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
John L Gore, Marguerite du Plessis, Jingbin Zhang, et al.
Page
of 50
Search research articles
Search
Showing results (381-390 of 498) with videos related to
Sort By:
Page
of 50
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2022
A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer
Liat Hammer, Ralph Jiang, Jason Hearn, et al.
JCO Precision Oncology
|
June 6, 2025
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
Angela Y Jia, Yilun Sun, Maitry Patel, et al.
The Lancet. Oncology
|
October 17, 2016
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
Shuang G Zhao, S Laura Chang, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)
Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
JCO Precision Oncology
|
October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
Journal of the National Cancer Institute
|
October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target
Shuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Cancer
|
April 15, 2023
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes
Adam B Weiner, Yang Liu, Alex Hakansson, et al.
Prostate Cancer and Prostatic Diseases
|
November 14, 2019
Prospective study to define the clinical utility and benefit of Decipher testing in men following prostatectomy
Joseph Marascio, Daniel E Spratt, Jingbin Zhang, et al.
Practical Radiation Oncology
|
November 26, 2019
Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial
John L Gore, Marguerite du Plessis, Jingbin Zhang, et al.
Page
of 50